TaiwanJ Pharmaceuticals Co., Ltd.

6549

TW0006549009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
13.25 ^TWD	-1.85%		+8.16%	-10.17%

Mar. 20	TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

TaiwanJ Pharmaceuticals Co., Ltd. announced that it expects to receive TWD 130 million in funding

December 12, 2017

TaiwanJ Pharmaceuticals Co., Ltd. (GTSM:6549) announced a private placement of 10,000,000 shares at a price of TWD 13 per share for gross proceeds of TWD 130,000,000 on December 13, 2017.

Latest news about TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-25	CI
TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
TaiwanJ Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Taiwanj Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-10	CI
Taiwanj Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-06	CI
Taiwanj Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-02	CI
Taiwanj Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-01	CI
Taiwanj Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-16	CI
TaiwanJ Pharmaceuticals Co., Ltd. Announces Positive Top-Line Results from Phase 2 Study of JKB-122 on Non-Alcoholic Fatty Liver Disease	18-10-24	CI
TaiwanJ Pharmaceuticals Co., Ltd. announced that it expects to receive TWD 130 million in funding	17-12-12	CI

Chart TaiwanJ Pharmaceuticals Co., Ltd.

Duration

Period

More charts

TaiwanJ Pharmaceuticals Co., Ltd. is a Taiwan-based company principally engaged in the research and development of new drugs. The Company is specialized in early research of new drugs and development of clinical drugs. The Company's products are used for the treatment of chronic liver diseases. The Company is in the development stage and not generating any revenue.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
TAIWANJ PHARMACEUTICALS CO., LTD.	-10.17%	31.09M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+1.76%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.67%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-12.74%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.18%	13.68B
SAREPTA THERAPEUTICS, INC.	+36.17%	12.17B